Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. (Leukemia and lymphoma, 2011)

(untitled) - Fitzgerald, D; Moskatel, E; Ben-Josef, G; Traini, R; Tendler, T; Sharma, A; Antignani, A; Mussai, F; Wayne, A; Kreitman, R; Pastan, I